Cargando…
A double-blinded, placebo-controlled randomized trial evaluating the efficacy and safety of Zhigancao Tang granules for treating HFpEF: study protocol for a randomized controlled trial
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by diastolic dysfunction. Despite the increasing incidence of HFpEF, there is no available therapy that reduces the mortality rate of HFpEF. Zhigancao Tang has been used traditionally for the trea...
Autores principales: | Zhang, Na, Zhao, Yingli, Liu, Yu, Tang, Nuo, Zheng, Wang, Mao, Meijiao, Liu, Qingcheng, Shen, Lin, Deng, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056488/ https://www.ncbi.nlm.nih.gov/pubmed/33879223 http://dx.doi.org/10.1186/s13063-021-05232-6 |
Ejemplares similares
-
Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022) -
Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trial
por: Backhaus, Sören J., et al.
Publicado: (2022) -
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
por: Borlaug, Barry A., et al.
Publicado: (2023) -
Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022) -
Hemodynamic force analysis is not ready for clinical trials on HFpEF
por: Arvidsson, Per M., et al.
Publicado: (2022)